Fetal pancreatic development & insulin secretion

胎儿胰腺发育

基本信息

  • 批准号:
    6882715
  • 负责人:
  • 金额:
    $ 51.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-04-01 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Provided By Applicant)The goal of this research project is to understand mechanisms regulating pancreatic development and function that are influenced by nutrients and secondary endocrine factors that augment the effects of nutrients and to focus specifically on the limited pancreatic growth and function in fetuses with intrauterine growth restriction (IUGR). We will test the hypothesis that reduced fetal nutrition from placental insufficiency will result in primary nutrient (glucose) and secondary hormonal (insulin, IGFs) deficiencies that lead to abnormal pancreatic endocrine development and function with 3 specific aims. 1. Analyze pancreatic development and function to define critical developmental periods and identify the adaptations imposed by decreased nutrient availability in the IUGR fetus. 2. Determine the effects of nutrient and hormonal deficiencies on insulin production and secretion in pancreatic endocrine cells in the IUGR fetus. 3. Test the ability to restore normal pancreatic development and function by in vivo nutrient and hormonal supplementation during critical periods of development in the IUGR fetus. The proposed studies will be conducted in our ovine model of IUGR produced by maternal exposure to a moderately hyperthermic environment during gestation. These fetuses develop hypoglycemia and hypoaminoacidemia and secondary deficiencies in insulin and GF concentrations in the latter third of gestation. in vivo and in vitro studies will characterize pancreatic development and function and determine mechanisms responsible for pancreatic abnormalities that are direct consequences of fetal nutrient deprivation. The studies also will provide insight into requirements for clinical interventions to ameliorate pancreatic insufficiency in IUGR fetuses and neonates, hopefully to reduce fetal and neonatal morbidity and mortality, and potentially to reduce the incidence of adult onset diseases that have been associated with low birth weight.
描述:(由申请人提供)本研究项目的目标是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William W Hay其他文献

EFFECT OF INCREASING GLUCOSE CONCENTRATION ALONE ON FETAL GLUCOSE UTILIZATION
  • DOI:
    10.1203/00006450-198704010-01040
  • 发表时间:
    1987-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Jane E Digiacomo;William W Hay;Frederick C Battaglia
  • 通讯作者:
    Frederick C Battaglia
Achieving Positive Protein Balance in the Immediate Post-Operative Period in Neonates with Amino Acid Administration Plus Narcotic Analgesia
  • DOI:
    10.1203/00006450-199904020-01642
  • 发表时间:
    1999-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Marianne S Anderson;Patti J Thureen;Karen A Baron;Kathryn D Bass;Diane L Melara;William W Hay
  • 通讯作者:
    William W Hay
Ovine Placental and Fetal Arginine Metabolism at Normal and Elevated Maternal Plasma Arginine Concentrations † 1577
  • DOI:
    10.1203/00006450-199804001-01599
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Patti J Thureen;Adrian W Pike;Karen A Baron;Paul V Fennessey;William W Hay
  • 通讯作者:
    William W Hay
185 COMPARISON OF UMBILICAL GLUCOSE UPTAKE AND FETAL GLUCOSE TURNOVER RATES
185 脐血葡萄糖摄取与胎儿葡萄糖周转率的比较
  • DOI:
    10.1203/00006450-197804001-00190
  • 发表时间:
    1978-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    William W Hay;John W Sparks;Barbara J Quissell;Frederick C Battaglia;Giacomo Meschia
  • 通讯作者:
    Giacomo Meschia
The Acute Effect of Selective Hyperglycemia and Hyperinsulinemia upon Fetal Ovine Glucose Transporter Proteins
选择性高血糖和高胰岛素血症对胎儿绵羊葡萄糖转运蛋白的急性影响
  • DOI:
    10.1203/00006450-199904020-00301
  • 发表时间:
    1999-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    U G Das;M Anderson;R A Erhardt;William W Hay;S U Devaskar
  • 通讯作者:
    S U Devaskar

William W Hay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William W Hay', 18)}}的其他基金

ARTERIAL OXYGEN PARTIAL PRESSURE AND BLOOD OXYGENATION FROM PULSE OXIMETRY
脉搏血氧饱和度的动脉血氧分压和血氧饱和度
  • 批准号:
    7605059
  • 财政年份:
    2007
  • 资助金额:
    $ 51.93万
  • 项目类别:
ARTERIAL OXYGEN PARTIAL PRESSURE AND BLOOD OXYGENATION FROM PULSE OXIMETRY
脉搏血氧饱和度的动脉血氧分压和血氧饱和度
  • 批准号:
    7202384
  • 财政年份:
    2005
  • 资助金额:
    $ 51.93万
  • 项目类别:
Arterial Oxygen Partial Pressure and Blood Oxygenation
动脉氧分压和血液氧合
  • 批准号:
    7041006
  • 财政年份:
    2004
  • 资助金额:
    $ 51.93万
  • 项目类别:
Fetal pancreatic development & insulin secretion
胎儿胰腺发育
  • 批准号:
    6422088
  • 财政年份:
    2002
  • 资助金额:
    $ 51.93万
  • 项目类别:
Fetal pancreatic development & insulin secretion
胎儿胰腺发育
  • 批准号:
    6723802
  • 财政年份:
    2002
  • 资助金额:
    $ 51.93万
  • 项目类别:
Fetal pancreatic development & insulin secretion
胎儿胰腺发育
  • 批准号:
    7046964
  • 财政年份:
    2002
  • 资助金额:
    $ 51.93万
  • 项目类别:
Fetal pancreatic development & insulin secretion
胎儿胰腺发育
  • 批准号:
    6612715
  • 财政年份:
    2002
  • 资助金额:
    $ 51.93万
  • 项目类别:
FETAL GLUCOSE AND AMINO ACID DEPRIVATION
胎儿血糖和氨基酸剥夺
  • 批准号:
    6332541
  • 财政年份:
    2000
  • 资助金额:
    $ 51.93万
  • 项目类别:
FETAL GLUCOSE AND AMINO ACID DEPRIVATION
胎儿血糖和氨基酸剥夺
  • 批准号:
    6296779
  • 财政年份:
    1999
  • 资助金额:
    $ 51.93万
  • 项目类别:
FETAL GLUCOSE AND AMINO ACID DEPRIVATION
胎儿血糖和氨基酸剥夺
  • 批准号:
    6108428
  • 财政年份:
    1999
  • 资助金额:
    $ 51.93万
  • 项目类别:

相似海外基金

Asymmetric Single-Chain MspA nanopores for electroosmotic stretching and sequencing proteins
用于电渗拉伸和蛋白质测序的不对称单链 MspA 纳米孔
  • 批准号:
    10646810
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Exploring the Role of Nitrogen Metabolism in Cancer
探索氮代谢在癌症中的作用
  • 批准号:
    10737792
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Discovery of neoepitope immunotherapeutic targets in diffuse pediatric high-grade gliomas
弥漫性儿童高级别胶质瘤中新表位免疫治疗靶点的发现
  • 批准号:
    10774404
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Detecting cell to cell contacts in zebrafish with a synthetic receptor methodology
使用合成受体方法检测斑马鱼的细胞与细胞接触
  • 批准号:
    10645331
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
  • 批准号:
    10698746
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
  • 批准号:
    10713648
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Identifying the Molecular Function of the Y-linked Mouse Zinc Finger Proteins ZFY1 and ZFY2
鉴定 Y 连锁小鼠锌指蛋白 ZFY1 和 ZFY2 的分子功能
  • 批准号:
    10749409
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
  • 批准号:
    10589578
  • 财政年份:
    2023
  • 资助金额:
    $ 51.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了